Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Orlic-Milacic, Marija, 2021-10-12

Class:IdInstanceEdit:9756231
_displayNameOrlic-Milacic, Marija, 2021-10-12
_timestamp2021-10-12 19:25:22
author[Person:1169272] Orlic-Milacic, Marija
dateTime2021-10-12 19:25:21
(modified)[PathwayDiagram:480128] Diagram of Mitotic G1 phase and G1/S transition, Defective binding of RB1 mutants to E2F1,(E2F2, E2F3), and Defective translocation of RB1 mutants to the nucleus
[Reaction:9754129] CDK6 inhibitors bind CDK6 [Homo sapiens]
[Reaction:9754130] CDK4 inhibitors bind CDK4 [Homo sapiens]
[CandidateSet:9755201] CDK4 inhibitors (CCND2) [nucleoplasm]
[CandidateSet:9755203] CDK6 inhibitors (CCND2) [nucleoplasm]
[Change default viewing format]
No pathways have been reviewed or authored by Orlic-Milacic, Marija, 2021-10-12 (9756231)